Clinical Trial Update: Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methotrexate versus cetuximab in first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Head Neck Cancer Squamous Cell Recurrent | Phase 3 | Status: COMPLETED